Journal rankings · indicator year 2023
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2023
Pulmonary and Respiratory Medicine journal rankings 2023
367 ranked journals · Subfield in Medicine
Pulmonary and Respiratory Medicine has 367 ranked journals in 2023. The median journal has an OJR of 0.69, below the world average of 1.00, up 0.02 on 2022; Q1 starts at OJR 1.01. The top three are The Lancet Respiratory Medicine, NEJM Evidence, and Drugs.
Ranks and citation indicators: 2023. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2020–2022, the window the 2023 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
367 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2022. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2020–2022, the window the 2023 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2020–2022 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2014 to 2023. | Compare |
|---|---|---|---|---|---|---|---|
1The Lancet Respiratory MedicineElsevier BV · Netherlands | 6.10Q1 | 17.78 15.40 down from 2022 | 691 | 59% | $7,280 | ||
2NEJM EvidenceUnited States | 5.02Q1 | 11.51 1.68 up from 2022 | 155 | 31% | — | ||
3DrugsAdis, Springer Healthcare · New Zealand | 4.25Q1 | 14.61 0.95 up from 2022 | 466 | 77% | $5,990 | ||
4European UrologyElsevier BV · Switzerland | 4.21Q1 | 10.42 1.77 down from 2022 | 740 | 8% | $5,250 | ||
5Intensive Care MedicineSpringer Science+Business Media · Germany | 3.91Q1 | 10.11 7.24 down from 2022 | 897 | 66% | $5,190 | ||
6Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom | 2.88Q1 | 7.12 0.94 down from 2022 | 2,227 | 99% | $5,100 | ||
7Journal of Thoracic OncologyElsevier BV · United States | 2.83Q1 | 9.37 0.74 down from 2022 | 779 | 100% | $4,100 | ||
8European Respiratory ReviewOAEuropean Respiratory Society · United Kingdom | 2.82Q1 | 10.75 1.89 up from 2022 | 299 | 100% | — | ||
9Clinical eHealthOAElsevier BV · China | 2.79Q1 | 7.60 2.97 down from 2022 | 38 | 100% | $995 | ||
10European Respiratory JournalEuropean Respiratory Society | 2.59Q1 | 8.66 1.87 down from 2022 | 1,606 | 53% | — | ||
11European Urology OncologyElsevier BV · Netherlands | 2.53Q1 | 7.91 0.01 up from 2022 | 253 | 42% | $3,790 | ||
12Modern PathologyElsevier BV · United States | 2.51Q1 | 7.61 0.96 down from 2022 | 586 | 100% | $4,480 | ||
13Critical CareOABioMed Central · United Kingdom | 2.45Q1 | 8.31 2.62 down from 2022 | 1,504 | 100% | $4,190 | ||
14American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States | 2.42Q1 | 6.75 2.14 down from 2022 | 1,708 | 82% | — | ||
15Gastric CancerSpringer Science+Business Media · Japan | 2.30Q1 | 6.40 1.28 down from 2022 | 298 | 97% | $3,590 | ||
16Annals of Intensive CareOASpringer Nature · France | 2.21Q1 | 6.36 2.53 down from 2022 | 458 | 100% | $3,490 | ||
17Clinics in Chest MedicineElsevier BV · United States | 2.21Q1 | 3.28 3.12 down from 2022 | 211 | 30% | $3,350 | ||
18Advances in Anatomic PathologyLippincott Williams & Wilkins · United States | 2.07Q1 | 4.32 1.91 down from 2022 | 122 | 18% | — | ||
19Medical SciencesOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.03Q1 | 6.05 0.26 up from 2022 | 193 | 100% | $1,689 | ||
20The Journal of UrologyLippincott Williams & Wilkins · United States | 2.03Q1 | 5.14 1.75 down from 2022 | 247 | 3% | $3,000 | ||
21ThoraxBMJ · United Kingdom | 2.01Q1 | 6.30 1.28 down from 2022 | 703 | 65% | — | ||
22PathologicaOAPacini Editore · Italy | 1.85Q1 | 3.49 0.43 down from 2022 | 155 | 100% | — | ||
23Seminars in Fetal and Neonatal MedicineElsevier BV · Netherlands | 1.80Q1 | 3.66 0.22 up from 2022 | 180 | 52% | $4,590 | ||
24LungSpringer Science+Business Media · Germany | 1.78Q1 | 5.16 0.78 down from 2022 | 265 | 48% | $4,290 | ||
25Respiratory ResearchOABioMed Central · United Kingdom | 1.77Q1 | 5.33 1.19 down from 2022 | 1,002 | 100% | $3,490 | ||
26Seminars in PerinatologyElsevier BV · United States | 1.65Q1 | 3.90 0.53 up from 2022 | 228 | 37% | $4,370 | ||
27Radiotherapy and OncologyElsevier BV · Netherlands | 1.65Q1 | 4.71 0.63 down from 2022 | 1,262 | 20% | $3,770 | ||
28Cancer ImagingOABioMed Central · United Kingdom | 1.64Q1 | 3.94 1.65 down from 2022 | 230 | 100% | $2,790 | ||
29Journal of Photochemistry and Photobiology B BiologyElsevier BV · Netherlands | 1.55Q1 | 4.36 1.45 down from 2022 | 583 | 27% | $4,110 | ||
30Seminars in Vascular SurgeryElsevier BV · United States | 1.53Q1 | 3.94 0.60 up from 2022 | 115 | 47% | $3,760 | ||
31Paediatric Respiratory ReviewsElsevier BV · United Kingdom | 1.51Q1 | 3.76 2.13 down from 2022 | 166 | 40% | $5,030 | ||
32JCO Precision OncologyLippincott Williams & Wilkins · United States | 1.48Q1 | 4.90 0.33 up from 2022 | 544 | 68% | — | ||
33Annals of the American Thoracic SocietyAmerican Thoracic Society · United States | 1.48Q1 | 4.11 0.70 down from 2022 | 899 | 66% | — | ||
34HistopathologyWiley · United Kingdom | 1.47Q1 | 3.62 1.05 down from 2022 | 632 | 66% | $4,840 | ||
35British Journal of UrologyWiley · United Kingdom | 1.46Q1 | 3.42 0.54 down from 2022 | 713 | 72% | $4,770 | ||
36Canine Medicine and GeneticsOABioMed Central · United Kingdom | 1.42Q1 | 5.09 2.57 up from 2022 | 41 | 100% | $1,990 | ||
37European Urology FocusElsevier BV · Netherlands | 1.41Q1 | 4.20 0.31 down from 2022 | 537 | 31% | $3,800 | ||
38Occupational and Environmental MedicineBMJ · United Kingdom | 1.41Q1 | 3.55 1.63 down from 2022 | 402 | 65% | — | ||
39BMJ Open Respiratory ResearchOABMJ · United Kingdom | 1.40Q1 | 4.33 0.48 down from 2022 | 383 | 100% | $2,085 | ||
40Advances in TherapyAdis, Springer Healthcare · United Kingdom | 1.38Q1 | 4.02 0.29 down from 2022 | 1,088 | 81% | $4,790 | ||
41Current Opinion in Critical CareLippincott Williams & Wilkins · United States | 1.38Q1 | 4.42 0.41 up from 2022 | 267 | 34% | — | ||
42Respiratory MedicineElsevier BV · United Kingdom | 1.37Q1 | 3.82 1.10 down from 2022 | 784 | 99% | $3,630 | ||
43Therapeutic Advances in Respiratory DiseaseOASAGE Publishing · United States | 1.36Q1 | 4.25 0.91 down from 2022 | 206 | 100% | $2,650 | ||
44Targeted OncologyAdis, Springer Healthcare · France | 1.34Q1 | 4.95 0.77 down from 2022 | 210 | 67% | $4,990 | ||
45Prostate Cancer and Prostatic DiseasesSpringer Nature · United Kingdom | 1.34Q1 | 4.76 0.03 up from 2022 | 407 | 52% | $5,190 | ||
46Lung CancerElsevier BV · Netherlands | 1.34Q1 | 4.43 0.18 down from 2022 | 856 | 26% | $3,390 | ||
47Journal of Aerosol ScienceElsevier BV · United Kingdom | 1.33Q1 | 4.50 1.54 down from 2022 | 344 | 52% | $2,850 | ||
48Frontiers in MedicineOAFrontiers Media · Switzerland | 1.32Q1 | 3.87 0.92 down from 2022 | 7,775 | 100% | $3,801 | ||
49CHEST JournalElsevier BV · United States | 1.31Q1 | 3.58 0.56 down from 2022 | 2,678 | 85% | $4,160 | ||
50Chronic Respiratory DiseaseOASAGE Publishing · United Kingdom | 1.31Q1 | 3.96 0.91 down from 2022 | 128 | 100% | $2,650 |
Subfields of Medicine, with Pulmonary and Respiratory Medicine highlighted.
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2023. Corpus-wide, 88.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
89 additional Pulmonary and Respiratory Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2020–2022, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2023. Publication window: 2020–2022. How these summaries are calculated
- Ranked journals
- 367
- Window papers (baseline)
- 218,275 +24.1% from indicator year 2020
- Median OJR
- 0.687 -5.8% from indicator year 2020
- Rising journals (2025)
- 26
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2020–2022 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 116 | 128 | 133 | 140 | 152 | 172 | 181 | 194 | 199 | 212 | 221 | 236 | 245 | 266 | 283 | 297 | 315 | 324 | 349 | 347 | 353 | 362 | 367 | 367 | 364 | 352 | |
| Window papers (baseline) | 51,191 | 58,101 | 61,730 | 66,053 | 67,282 | 74,504 | 82,746 | 93,558 | 102,120 | 113,728 | 123,057 | 131,093 | 135,018 | 138,763 | 146,389 | 152,077 | 157,160 | 158,971 | 164,168 | 168,770 | 175,931 | 189,625 | 206,647 | 218,275 | 218,995 | 219,470 | |
| Median OJR | 0.56 | 0.57 | 0.55 | 0.628 | 0.671 | 0.663 | 0.713 | 0.664 | 0.693 | 0.70 | 0.767 | 0.80 | 0.84 | 0.768 | 0.75 | 0.731 | 0.689 | 0.6662 | 0.68 | 0.710 | 0.730 | 0.6663 | 0.665 | 0.687 | 0.64 | 0.633 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.